Abrdn Healthcare Investors

Abrdn Healthcare Investors

HQH·NYSE

$18.99

-0.89%
Financial ServicesAsset Management

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

At a Glance

Live Snapshot
Market Cap$1.09B
EPS1.8400
P/E Ratio10.32
Earnings Date
hqh

Abrdn Healthcare Investors Street Expectations Map

HQH · NYSE

No Target Data

No analyst price targets available for hqh.

hqh

Abrdn Healthcare Investors Forward Estimates of Revenue

HQH · NYSE
Latest Revenue
99.81M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

hqh

Abrdn Healthcare Investors Forward Estimates of Net Income

HQH · NYSE
Latest Net Income
98.61M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

hqh

Abrdn Healthcare Investors Forward Estimates of EPS

HQH · NYSE
Latest EPS
1.84
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

hqh

Abrdn Healthcare Investors Forward Estimates of EBIT

HQH · NYSE
Latest EBIT
98.61M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

hqh

Abrdn Healthcare Investors Forward Estimates of EBITDA

HQH · NYSE
Latest EBITDA
98.61M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

hqh

Abrdn Healthcare Investors Forward Estimates of SG&A Expense

HQH · NYSE
Latest SG&A Expense
1.14M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

hqh

Abrdn Healthcare Investors Insider Positioning

HQH · NYSE

During the last 12 months, there has been no insider trading activity reported for HQH.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Neutral

No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.

Insider Participation

No Activity

No insider trading activity reported from any insiders in the past year.